Array
the Food and Drug Administration issued an emergency use authorization for over-the-counter sale to Lucira Health’s combination COVID-flu disposable at-home test.
The Lucira test is the first such combination kit to be issued over-the-counter emergency authorization by the FDA, and no prescription is required. Users take nasal swabs, collect samples and in 30 minutes know whether or not they have the flu or COVID-19.
A Lucira combination COVID-flu test for point-of-care use in healthcare settings was authorized in November 2022.
The test accurately identified 99.3% of negatives and 90.1% for positives of the influenza A strain, 99.
